Colorectal cancer screening is widely recommended to adults ages 45-75 with a risk of developing the disease, but a new study worked on by U-M researchers reports that this practice leads to over-screening, and the benefits of screening vary across patients. Instead, they recommend a personalized approach to screening, where patients work together with their physicians to ensure they’re receiving the maximum possible benefit from their healthcare. Read about the study and its findings in this article from the Institute of Healthcare Policy and Innovation.
